Oracle and AstraZeneca: Bringing Clinical Trials Closer to Care
Dr. Dereck Mush, MD, MBA
Acclinate
Platform helping biopharmaceutical companies access and engage diverse clinical trial participants.
What they do
Acclinate leverages digital community engagement to help pharmaceutical sponsors improve clinical trial diversity. The company utilises its proprietary platform to build trust and educate underrepresented communities, ensuring clinical trials reflect real world patient demographics.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Patient recruitment
- Product type
- Service
- Stage
- Series A
- Headquarters
- Birmingham, United States
- Region
- North America
- Founded
- 2020
- Total funding
- $7M raised
Notable investors: Overline, Bronze Valley, Collab Capital.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA
Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA